Saturday, December 13, 2008 2:04:04 PM
They who do not control their mind live to be destroyed by it.
Recent EBS News
- Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis • GlobeNewswire Inc. • 03/28/2024 12:15:03 PM
- Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility • GlobeNewswire Inc. • 03/25/2024 12:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/08/2024 09:21:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 01:31:51 AM
- Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results • GlobeNewswire Inc. • 03/06/2024 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:15:47 PM
- U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb • IH Market News • 03/06/2024 11:02:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:43:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:42:33 PM
- Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024 • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:30:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:28:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:25:51 PM
- Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 12:41:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 01:40:06 PM
- Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 • GlobeNewswire Inc. • 01/09/2024 12:30:00 PM
- Wall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and More • IH Market News • 12/27/2023 11:08:22 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/11/2023 10:22:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/11/2023 12:24:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 12:15:22 PM
- Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted) • GlobeNewswire Inc. • 11/28/2023 11:59:00 AM
- Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing • GlobeNewswire Inc. • 11/24/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 12:17:42 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM